COMPANY PROFILE // THE 014 REPORT
Nuwellis, Inc.
NUWE (Nasdaq) · Formerly: CHF Solutions, Inc.; Sunshine Heart, Inc.
Assembled from 4 government sources in 0.1 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- AmberLEI 54930007LBO6YS5KNX75 registration status is LAPSED (last update 2026-11-10): the legal-entity record has not been renewed.
- Amber6 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-06-18: a pattern of leadership change.
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2025-06-23 (last 24 months).
- InfoGLEIF: no direct parent reported; reporting exception reason NON_CONSOLIDATING.
✓ SEC filings✓ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
Nuwellis, Inc. is an SEC-registered operating company in electromedical & electrotherapeutic apparatus, incorporated in DE, based in Eden Prairie, MN; listed as NUWE (Nasdaq).[source] It reported revenue of $8.3 million for the fiscal year ended 2025-12-31.[source] It has filed 66 documents with the SEC in the last 12 months; the latest is Form 8-K, filed 2026-11-17.[source] Its largest institutional holders on 13F filings are SABBY MANAGEMENT, LLC, UBS Group AG, Tower Research Capital LLC (TRC) (as of 2026-06-30).[source] Seraphix flags 3 items from these records: 8-K Item 3.01 filed; 6 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-06-18; LEI 54930007LBO6YS5KNX75 registration status is LAPSED (last update 2026-11-10).[source]
- red0
- amber3
- info1
- SABBY MANAGEMENT, LLC$50K
- UBS Group AG$13K
- Tower Research Capital LLC (TRC)$421
- SBI Securities Co., Ltd.$12
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- ERB JOHN L · CEO and President (Director,Officer,10% owner) · latest Form 4 2025-07-01 · filing · LinkedIn search
- Schultz Carisa · Chief Financial Officer (Officer) · latest Form 3 2026-02-12 · filing · LinkedIn search
- Emerson Martin J · Director · latest Form 3 2026-03-18 · filing · LinkedIn search
- Feldshon Archelle Georgiou · Director · latest Form 4 2025-05-21 · filing · LinkedIn search
- Field Katharyn · Director · latest Form 3 2026-02-11 · filing · LinkedIn search
- Grasso Mika · Director · latest Form 3 2026-02-11 · filing · LinkedIn search
- McCormick Michael Kendrick · Director · latest Form 4 2025-05-21 · filing · LinkedIn search
- McDonald David · Director · latest Form 3 2026-03-02 · filing · LinkedIn search
- WALLER GREGORY D · Director · latest Form 4 2025-05-21 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
Legal counsel, as publicly named
- Honigman LLP · Exhibit 5.1 legal opinion, S-3 filed 2026-08-18
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001506492 | source |
| LEI | 54930007LBO6YS5KNX75 | source |
| EIN | 68-0533453 | source |
| Business address (SEC) | 12988 VALLEY VIEW ROAD, EDEN PRAIRIE, MN, 55344 | source |
Does not exist in the records we hold: UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2026-11-10 · in -10 days · LEI next renewal (54930007LBO6YS5KNX75)
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 3845 (electromedical & electrotherapeutic apparatus): 31 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- CONMED Corp · 61 SEC filings in 12 months · 1 flag · $5.8M federal (possible match)
- LivaNova PLC · 64 SEC filings in 12 months · 2 flags · $5.8M federal (possible match)
- IRIDEX CORP · 67 SEC filings in 12 months · 1 flag · $1.1M federal (possible match)
- electroCore, Inc. · 48 SEC filings in 12 months · 2 flags · $968K federal (possible match)
- ESCALON MEDICAL CORP · 7 SEC filings in 12 months · 2 flags · $160K federal (possible match)
- Integer Holdings Corp · 109 SEC filings in 12 months · 2 flags · $120K federal (possible match)
- Neuraxis, INC · 53 SEC filings in 12 months · $81K federal (possible match)
- Electromed, Inc. · 35 SEC filings in 12 months · $15K federal (possible match)
- Outset Medical, Inc. · 90 SEC filings in 12 months · 2 flags · $600 federal (possible match)
- Ceribell, Inc. · 184 SEC filings in 12 months
- Medtronic plc · 140 SEC filings in 12 months
- CapsoVision, Inc · 67 SEC filings in 12 months
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
Shared directors and officers
- LOGPROSTYLE INC. · Field Katharyn
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-17 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-11-12 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-12 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-10-23 filing 8-K items 3.03,5.03,9.01 · SEC EDGAR
- 2026-08-26 filing EFFECT · SEC EDGAR
- 2026-08-26 filing 424B3 · SEC EDGAR
- 2026-08-26 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-08-18 filing S-3 · SEC EDGAR
- 2026-08-13 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-08-13 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-03 filing 8-K items 1.01,3.02,8.01,9.01 · SEC EDGAR
- 2026-08-03 filing 424B5 · SEC EDGAR
- 2026-07-24 filing 8-K items 5.07 · SEC EDGAR
- 2026-07-07 filing Proxy statement · SEC EDGAR
- 2026-06-26 filing PRE 14A · SEC EDGAR
- 2026-06-24 filing 8-K items 3.03,5.03,9.01 · SEC EDGAR
- 2026-06-18 officer change 8-K items 5.02,7.01,9.01 · SEC EDGAR
- 2026-06-10 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-06-08 filing 424B4 · SEC EDGAR
- 2026-06-05 filing S-1MEF · SEC EDGAR
- 2026-06-04 filing EFFECT · SEC EDGAR
- 2026-06-04 filing CORRESP · SEC EDGAR
- 2026-06-04 filing S-1/A · SEC EDGAR
- 2026-06-02 filing FWP · SEC EDGAR
- 2026-05-29 filing S-1/A · SEC EDGAR
- 2026-05-28 filing SD · SEC EDGAR
- 2026-05-22 filing Registration (S-1) · SEC EDGAR
- 2026-05-15 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-12 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-04-29 filing 8-K items 5.07 · SEC EDGAR
170 earlier entries
- 2026-04-24 filing 8-K items 8.01
- 2026-04-06 filing DEFA14A
- 2026-04-02 filing ARS
- 2026-04-02 filing Proxy statement
- 2026-04-01 officer change 8-K/A items 5.02,9.01
- 2026-03-27 officer change 8-K items 5.02,9.01
- 2026-03-18 insider First Form 3/4/5 on record for Emerson Martin J (Director)
- 2026-03-17 filing 8-K items 8.01
- 2026-03-11 filing Annual report (10-K)
- 2026-03-10 filing 8-K items 2.02,9.01
- 2026-02-26 officer change 8-K items 5.02,7.01,8.01,9.01
- 2026-02-12 insider First Form 3/4/5 on record for Schultz Carisa (Chief Financial Officer)
- 2026-02-11 insider First Form 3/4/5 on record for Field Katharyn (Director)
- 2026-02-11 insider First Form 3/4/5 on record for Grasso Mika (Director)
- 2026-02-09 filing EFFECT
- 2026-02-09 filing 424B3
- 2026-02-06 filing CORRESP
- 2026-02-05 filing UPLOAD
- 2026-02-04 filing S-3
- 2026-01-30 officer change 8-K items 1.01,3.02,3.03,5.02,7.01,9.01
- 2026-01-23 officer change 8-K items 5.02,7.01,9.01
- 2025-11-25 filing DRS
- 2025-11-12 filing Quarterly report (10-Q)
- 2025-11-12 filing 8-K items 2.02,9.01
- 2025-10-08 officer change 8-K items 5.02
- 2025-09-30 filing 8-K items 8.01
- 2025-09-18 filing 8-K items 8.01
- 2025-09-09 filing 8-K items 8.01
- 2025-09-03 filing 8-K items 1.01,9.01
- 2025-09-03 filing 424B5
- 2025-08-21 filing 8-K items 8.01
- 2025-08-19 filing 8-K items 8.01
- 2025-08-14 filing Quarterly report (10-Q)
- 2025-08-14 filing 8-K items 2.02,9.01
- 2025-08-04 filing 8-K items 5.07
- 2025-07-23 filing 8-K items 8.01
- 2025-07-14 filing Proxy statement
- 2025-07-03 filing PRE 14A
- 2025-07-02 officer change 8-K items 3.03,5.02,5.03,9.01
- 2025-06-23 filing 8-K items 3.01
- 2025-06-16 filing SCHEDULE 13D
- 2025-06-11 insider First Form 3/4/5 on record for ERB JOHN L (CEO and President)
- 2025-06-10 filing 424B4
- 2025-06-09 filing EFFECT
- 2025-06-09 filing 8-K items 1.01,3.02,5.03,9.01
- 2025-06-05 filing CORRESP
- 2025-06-05 filing CORRESP
- 2025-06-03 filing S-1/A
- 2025-05-30 filing Registration (S-1)
- 2025-05-29 filing SD
- 2025-05-22 filing 8-K items 5.07
- 2025-05-21 insider First Form 3/4/5 on record for Feldshon Archelle Georgiou (Director)
- 2025-05-21 insider First Form 3/4/5 on record for McCormick Michael Kendrick (Director)
- 2025-05-21 insider First Form 3/4/5 on record for McDonald David (Director)
- 2025-05-21 insider First Form 3/4/5 on record for WALLER GREGORY D (Director)
- 2025-05-13 filing Quarterly report (10-Q)
- 2025-05-13 filing 8-K items 2.02,9.01
- 2025-05-12 filing 8-K items 1.01,9.01
- 2025-05-09 filing DEFR14A
- 2025-04-17 filing UPLOAD
- 2025-04-14 filing ARS
- 2025-04-14 filing Proxy statement
- 2025-04-11 filing DRS
- 2025-04-03 filing 8-K items 7.01,9.01
- 2025-04-01 filing PRE 14A
- 2025-03-11 filing Annual report (10-K)
- 2025-03-11 filing 8-K items 2.02,9.01
- 2025-02-24 officer change 8-K items 5.02,7.01,9.01
- 2024-12-20 filing EFFECT
- 2024-12-20 filing 424B3
- 2024-12-20 filing CORRESP
- 2024-12-19 filing S-1/A
- 2024-12-19 filing 8-K items 8.01,9.01
- 2024-12-16 filing 8-K items 8.01
- 2024-11-22 filing UPLOAD
- 2024-11-20 filing D
- 2024-11-15 filing Registration (S-1)
- 2024-11-12 filing Quarterly report (10-Q)
- 2024-11-12 filing 8-K items 2.02,9.01
- 2024-11-07 filing 8-K items 1.01,3.02,3.03,8.01,9.01
- 2024-11-01 filing 8-K items 2.02,9.01
- 2024-10-23 filing 8-K items 1.02,9.01
- 2024-09-06 filing EFFECT
- 2024-09-06 filing 424B3
- 2024-09-04 filing CORRESP
- 2024-09-04 filing D
- 2024-08-29 filing S-1/A
- 2024-08-26 filing 8-K items 1.01,3.02,7.01,9.01
- 2024-08-26 filing 424B5
- 2024-08-22 filing 8-K items 1.02,9.01
- 2024-08-21 filing UPLOAD
- 2024-08-15 filing Registration (S-1)
- 2024-08-13 filing Quarterly report (10-Q)
- 2024-08-13 filing 8-K items 2.02,9.01
- 2024-08-12 filing 8-K items 3.01
- 2024-08-02 filing D
- 2024-07-25 filing 424B5
- 2024-07-25 filing 8-K items 1.01,3.02,7.01,9.01
- 2024-07-17 filing 8-K/A items 8.01,9.01
- 2024-07-17 filing 8-K items 7.01,8.01,9.01
- 2024-07-17 filing 8-K items 8.01,9.01
- 2024-07-09 filing EFFECT
- 2024-07-08 filing CORRESP
- 2024-07-08 filing UPLOAD
- 2024-07-03 filing 8-K items 1.02
- 2024-07-01 filing S-3
- 2024-06-26 filing 8-K items 3.03,5.03,7.01,9.01
- 2024-06-10 filing 8-K items 3.01,5.07
- 2024-06-06 filing 8-K items 1.01,8.01,9.01
- 2024-05-29 filing 8-K items 3.01,8.01
- 2024-05-29 filing SD
- 2024-05-17 filing ARS
- 2024-05-17 filing DEFR14A
- 2024-05-08 filing Quarterly report (10-Q)
- 2024-05-08 filing PRER14A
- 2024-05-07 filing 8-K items 2.02,9.01
- 2024-05-01 filing Proxy statement
- 2024-05-01 filing 8-K items 1.01,8.01,9.01
- 2024-04-29 filing 424B4
- 2024-04-26 filing EFFECT
- 2024-04-22 filing CORRESP
- 2024-04-22 filing CORRESP
- 2024-04-22 filing CORRESP
- 2024-04-22 filing CORRESP
- 2024-04-17 filing CORRESP
- 2024-04-17 filing CORRESP
- 2024-04-17 filing S-1/A
- 2024-04-09 filing PRE 14A
- 2024-03-26 filing 8-K items 8.01
- 2024-03-13 filing S-1/A
- 2024-03-11 filing Annual report (10-K)
- 2024-03-06 filing 8-K items 2.02,9.01
- 2024-02-14 filing CORRESP
- 2024-02-14 filing CORRESP
- 2024-02-09 filing CORRESP
- 2024-02-09 filing CORRESP
- 2024-02-08 filing S-1/A
- 2024-02-06 filing 8-K items 8.01,9.01
- 2024-02-05 filing S-1/A
- 2024-01-31 filing S-1/A
- 2024-01-26 filing UPLOAD
- 2024-01-18 filing Registration (S-1)
- 2024-01-09 filing 8-K/A items 7.01,9.01
- 2024-01-08 filing 8-K items 7.01,9.01
- 2023-12-13 filing 8-K items 3.01
- 2023-11-07 filing Quarterly report (10-Q)
- 2023-11-07 filing 8-K items 2.02,9.01
- 2023-11-01 officer change 8-K items 5.02,9.01
- 2023-10-17 filing 8-K items 1.01,3.03,5.03,8.01,9.01
- 2023-10-16 filing 424B4
- 2023-10-10 filing 8-K items 8.01,9.01
- 2023-10-06 filing POS462C
- 2023-10-05 filing AW
- 2023-10-04 filing POS AM
- 2023-09-29 filing EFFECT
- 2023-09-29 filing CORRESP
- 2023-09-29 filing CORRESP
- 2023-09-29 filing S-1/A
- 2023-09-27 filing UPLOAD
- 2023-09-21 filing Registration (S-1)
- 2023-08-18 officer change 8-K items 5.02,9.01
- 2023-08-08 filing Quarterly report (10-Q)
- 2023-08-08 officer change 8-K items 5.02,7.01,9.01
- 2023-08-08 filing 8-K items 2.02,9.01
- 2023-06-26 filing D
- 2023-06-21 filing 8-K items 1.01,3.02,8.01,9.01
- 2023-06-05 officer change 8-K items 5.02,9.01
- 2023-05-25 filing SD
- 2023-05-22 filing 8-K items 5.07
- 2023-05-09 filing Quarterly report (10-Q)
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-17 (within 7 days) 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-11-12 (within 30 days) 10-Q filed
- 2026-11-12 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-23 (within 30 days) 8-K filed: Item 3.03 rights of holders modified; Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-09-10 (older) Contract 36C25626P1071 awarded by Department of Veterans Affairs, $90,600 obligated to date
- 2026-08-26 (older) EFFECT filed
- 2026-08-26 (older) 424B3 filed
- 2026-08-26 (older) 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:NUWE The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
1 possible match held apart, matched by name only, not counted above; 2 records under a former name, shown apart.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1506492 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | NUWE / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| LEI (root of the ownership tree) | 54930007LBO6YS5KNX75 | id:lei-family: legal entity in this company's GLEIF ownership tree (LEI 54930007LBO6YS5KNX75) | GLEIF |
| EIN | 680533453 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001506492 | SEC EDGAR / IRS |
| CUSIP | 67113Y801 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001506492 | SEC EDGAR |
| UEI | TB7FDF5LDCJ4 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001506492 | USAspending |
former name (shown apart, not merged) (2)
- former nameCHF SOLUTIONS INC · EPA ECHO facilities
- former nameCHF SOLUTIONS, INC. · New York corporations
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $8,270,000 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-20 07:04 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | -$17,521,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-20 07:04 UTC | Report an error |
| Total assets (at 2025-12-31) | $6,118,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-20 07:04 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $2,624,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-20 07:04 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $1,085,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-20 07:04 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 07:04 UTC | Report an error |
| SIC industry | 3845 Electromedical & Electrotherapeutic Apparatus | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 07:04 UTC | Report an error |
| State of incorporation | DE | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 07:04 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 07:04 UTC | Report an error |
| Business address | 12988 VALLEY VIEW ROAD, EDEN PRAIRIE, MN, 55344 | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 07:04 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-17 | SEC EDGAR company profile | as filed | 2026-11-20 07:04 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$10,810,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 07:04 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $90,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-20 07:04 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $307,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-20 07:04 UTC | Report an error |
| Form D total offering amount (D filed 2024-11-20) | $3,848,286 | 2024-11-20 | D | as filed | 2026-11-20 07:04 UTC | Report an error |
| Form D total amount sold (D filed 2024-11-20) | $3,848,286 | 2024-11-20 | D | as filed | 2026-11-20 07:04 UTC | Report an error |
| Form D industry group | Other Health Care | 2024-11-20 | D | as filed | 2026-11-20 07:04 UTC | Report an error |
| Form D revenue range | $5,000,001 - $25,000,000 | 2024-11-20 | D | as filed | 2026-11-20 07:04 UTC | Report an error |
| Form D date of first sale | 2024-11-06 | 2024-11-20 | D | as filed | 2026-11-20 07:04 UTC | Report an error |
| Federal award transactions, fiscal year 2026 (this one registration only) | $90,600 | 2026-09-30 | USAspending recipient profile | as filed | 2026-11-20 07:04 UTC | Report an error |
| Number of federal award transactions, fiscal year 2026 (this one registration only) | 1 | 2026-09-30 | USAspending recipient profile | as filed | 2026-11-20 07:04 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-12 · accession 0001140361-26-043425
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $2,212,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-12 | 0001140361-26-043425 | 2026-11-20 07:04 UTC | Report an error |
| Net income (loss) | -$1,969,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-12 | 0001140361-26-043425 | 2026-11-20 07:04 UTC | Report an error |
| Cash and cash equivalents | $8,290,000 | at 2026-09-30 | 10-Q | 2026-11-12 | 0001140361-26-043425 | 2026-11-20 07:04 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-17 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-11-12 Filing 10-Q filed
- 2026-11-12 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-23 Filing 8-K filed: Item 3.03 rights of holders modified; Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-09-10 Contract Contract 36C25626P1071 awarded by Department of Veterans Affairs, $90,600 obligated to date
- 2026-08-26 Filing EFFECT filed
- 2026-08-26 Filing 424B3 filed
- 2026-08-26 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-08-18 Filing S-3 filed
- 2026-08-13 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-13 Filing 10-Q filed
- 2026-08-03 Filing 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 8.01 other event; Item 9.01 exhibits
- 2026-08-03 Filing 424B5 filed
- 2026-07-24 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-07-07 Filing DEF 14A filed (FORM DEF 14A)
- 2026-06-26 Filing PRE 14A filed
- 2026-06-24 Filing 8-K filed: Item 3.03 rights of holders modified; Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-06-18 Filing 8-K filed: Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-06-10 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-06-08 Filing 424B4 filed
- 2026-06-05 Filing S-1MEF filed
- 2026-06-04 Filing EFFECT filed
- 2026-06-04 Filing CORRESP filed
- 2026-06-04 Filing S-1/A filed
- 2026-06-02 Filing FWP filed
2 earlier entries
- 2026-05-29 Filing S-1/A filed
- 2025-09-04 Contract Contract 36C24225P1357 awarded by Department of Veterans Affairs, $20,000 obligated to date
8-K item text, as filed (excerpts)
- 2026-11-17 8-K Item 7.01
Regulation FD Disclosure. On November 17, 2026, Nuwellis, Inc. (the “Company”) posted an updated corporate presentation to its website at https://nuwellis.com/investors/, which the Company may use from time to time in presentations, investor communications or conferences. A copy of the corporate presentation is attached as Exhibit 99.1 to this Current Report on Form 8-K (this “Report”) and is incorporated herein by reference. Information contained on or accessible through any website reference in the corporate presentation is not part of, or incorporated by reference in, this Report, and the inclusion of such website addresses in this Report by incorporation by reference of the corporate… the 8-K · retrieved 2026-11-20 07:04 UTC - 2026-11-12 8-K Item 2.02
Results of Operations and Financial Condition. On November 12, 2026, Nuwellis, Inc. (the “Company”) issued a press release reporting its financial results for the three months ended September 30, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. In accordance with General Instruction B.2 of Form 8-K, the information included in this Current Report on Form 8-K (including Exhibit 99.1) is furnished pursuant to Item 2.02 and shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. the 8-K · retrieved 2026-11-20 07:04 UTC - 2026-10-23 8-K Item 3.03
Material Modification to Rights of Security Holders. To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Report on Form 8-K is incorporated herein by reference. the 8-K · retrieved 2026-11-20 07:04 UTC - 2026-10-23 8-K Item 5.03
Amendment to Articles of Incorporation or Bylaws, Change in Fiscal Year. As previously disclosed, on July 24, 2026, the Company held a special meeting of stockholders (the “Special Meeting”). At the Special Meeting, the stockholders approved a proposal to amend the Company’s Fourth Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to effect a reverse stock split of its outstanding common stock at a ratio in the range of one-for-five to one-for-seventy, to be determined at the discretion of the Board of Directors of the Company (the “Board”). On October 13, 2026, the Board approved a one-for-nine reverse stock split of the Company’s issued… the 8-K · retrieved 2026-11-20 07:04 UTC - 2026-08-26 8-K Item 7.01
Regulation FD Disclosure. On August 25, 2026, Nuwellis, Inc. (the “Company”) posted an updated corporate presentation to its website at ir.nuwellis.com, which the Company may use from time to time in presentations, investor communications or conferences. A copy of the corporate presentation is attached as Exhibit 99.1 to this Current Report on Form 8-K (this “Report”) and is incorporated herein by reference. Information contained on or accessible through any website reference in the corporate presentation is not part of, or incorporated by reference in, this Report, and the inclusion of such website addresses in this Report by incorporation by reference of the corporate presentation is as… the 8-K · retrieved 2026-11-20 07:04 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | SABBY MANAGEMENT, LLC | $49,935 | 2026-06-30 | SEC 13F filing | 2026-11-20 07:04 UTC | Report an error |
| 2 | UBS Group AG | $13,466 | 2026-06-30 | SEC 13F filing | 2026-11-20 07:04 UTC | Report an error |
| 3 | Tower Research Capital LLC (TRC) | $421 | 2026-06-30 | SEC 13F filing | 2026-11-20 07:04 UTC | Report an error |
| 4 | SBI Securities Co., Ltd. | $12 | 2026-06-30 | SEC 13F filing | 2026-11-20 07:04 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
GLEIF OWNERSHIP TREE · ID TIER11. Subsidiaries
1 legal entity in the company's GLEIF ownership tree, joined by LEI (an official identifier).
- Nuwellis, Inc. · LEI 54930007LBO6YS5KNX75 · root
Exhibit 21 subsidiaries: not held yet.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
1 state and city record carry this company's exact name, from 1 source. Possible matches only.
ClinicalTrials.gov (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchNuwellis, Inc. · exact legal name · sx:ctgov:hb9e6c5ac216221f2 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1506492.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001506492. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.